Sarepta Therapeutics, Inc. (SRPT)
20.64
+0.12
(+0.58%)
USD |
NASDAQ |
Sep 11, 15:41
Sarepta Therapeutics Gross Profit (TTM) : 1.117B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.117B |
| March 31, 2026 | 1.323B |
| December 31, 2025 | 1.309B |
| September 30, 2025 | 1.791B |
| June 30, 2025 | 1.926B |
| March 31, 2025 | 1.788B |
| December 31, 2024 | 1.545B |
| September 30, 2024 | 1.371B |
| June 30, 2024 | 1.289B |
| March 31, 2024 | 1.196B |
| December 31, 2023 | 1.049B |
| September 30, 2023 | 924.44M |
| June 30, 2023 | 820.19M |
| March 31, 2023 | 789.67M |
| December 31, 2022 | 751.16M |
| September 30, 2022 | 693.66M |
| June 30, 2022 | 669.51M |
| March 31, 2022 | 619.83M |
| December 31, 2021 | 566.82M |
| September 30, 2021 | 522.70M |
| June 30, 2021 | 489.52M |
| March 31, 2021 | 470.94M |
| December 31, 2020 | 449.81M |
| September 30, 2020 | 418.71M |
| June 30, 2020 | 382.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 343.19M |
| December 31, 2019 | 323.40M |
| September 30, 2019 | 310.12M |
| June 30, 2019 | 293.86M |
| March 31, 2019 | 281.90M |
| December 31, 2018 | 265.98M |
| September 30, 2018 | 248.43M |
| June 30, 2018 | 220.99M |
| March 31, 2018 | 187.15M |
| December 31, 2017 | 142.80M |
| September 30, 2017 | 92.91M |
| June 30, 2017 | 49.74M |
| March 31, 2017 | 15.53M |
| December 31, 2016 | -0.32M |
| September 30, 2016 | -3.947M |
| June 30, 2016 | -4.185M |
| March 31, 2016 | -4.00M |
| December 31, 2015 | -3.883M |
| September 30, 2015 | -3.883M |
| June 30, 2015 | -2.571M |
| March 31, 2015 | -1.28M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Moderna, Inc. | 280.00M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Beam Therapeutics, Inc. | 133.79M |
| Twist Bioscience Corp. | 224.38M |
| ImmunityBio, Inc. | 148.09M |